ClinicalTrials.Veeva

Menu

E-cigarettes and Blood Vessel Function

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status

Completed

Conditions

Nicotine Dependence

Treatments

Other: one time exposure to empty e-cig
Other: one time exposure to e-cig with nicotine
Other: one time exposure to e-cig without nicotine

Study type

Interventional

Funder types

Other

Identifiers

NCT02740595
14-000743

Details and patient eligibility

About

Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, and sham control, on endothelial function and markers of oxidative stress.

Full description

Participants will use an electronic cigarette on 3 occasions: 1) with nicotine, 2) without nicotine, 3) sham control, and undergo a measure of endothelial function called brachial artery flow mediated dilatation (FMD). Additionally, oxidative stress will be measured pre and post exposure.

Enrollment

148 patients

Sex

All

Ages

21 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy

Exclusion criteria

  • Cardiac disease
  • Respiratory disease
  • Diabetes mellitus

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

148 participants in 3 patient groups

Nicotine
Experimental group
Description:
Use an e-cig filled with liquid with nicotine
Treatment:
Other: one time exposure to e-cig with nicotine
no nicotine
Experimental group
Description:
Use an e-cig filled with liquid without nicotine
Treatment:
Other: one time exposure to e-cig without nicotine
sham comparator
Sham Comparator group
Description:
Use an empty e-cigarette (sham control)
Treatment:
Other: one time exposure to empty e-cig

Trial contacts and locations

1

Loading...

Central trial contact

Holly R Middlekauff, MD; Kacey Peters, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems